Kidney Biopsy Global Market Report 2024

Description

A kidney biopsy, also referred to as a renal biopsy, is a medical procedure where a small sample of kidney tissue is extracted for microscopic analysis. This procedure is commonly conducted to diagnose kidney conditions, evaluate the severity of existing kidney diseases, or monitor treatment effectiveness. It plays a crucial role in identifying diverse kidney disorders such as glomerulonephritis, interstitial nephritis, and nephrotic syndrome, offering insights into the underlying causes of kidney dysfunction.

The primary types of kidney biopsy include percutaneous biopsy and surgical biopsy. Percutaneous biopsy involves inserting a needle through the skin to obtain tissue samples from the kidney for examination. This method is utilized in various clinical settings including cases of kidney failure, kidney transplantation, hematuria, and proteinuria. It is employed by hospitals, clinics, urology centers, tertiary care centers, and other healthcare facilities.

The kidney biopsy market research report is one of a series of new reports from The Business Research Company that provides kidney biopsy market statistics, including the kidney biopsy industry global market size, regional shares, competitors with kidney biopsy market share, detailed kidney biopsy market segments, market trends, and opportunities, and any further data you may need to thrive in the kidney biopsy industry. These kidney biopsy market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The kidney biopsy market size has grown strongly in recent years. It will grow from $2.03 billion in 2023 to $2.14 billion in 2024 at a compound annual growth rate (CAGR) of 5.3%. The growth observed in the historical period can be attributed to several factors, increased prevalence of chronic kidney diseases, heightened awareness and emphasis on early diagnosis, growth in the geriatric population, expansion of healthcare infrastructure, enhanced government initiatives aimed at kidney disease management, and rising awareness regarding kidney health.

The kidney biopsy market size is expected to see strong growth in the next few years. It will grow to $2.66 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. The anticipated growth in the forecast period can be attributed to several key factors, the increasing prevalence of kidney diseases, rising healthcare expenditure globally, growing awareness about the importance of early diagnosis and treatment of kidney conditions, expanding geriatric population requiring specialized care, rising demand for minimally invasive medical procedures, and increasing research activities focused on improving kidney health outcomes. Major trends expected in this period include advancements in biopsy techniques with a focus on minimally invasive approaches, adoption of sophisticated imaging technologies for precise diagnosis, integration of artificial intelligence to enhance diagnostic accuracy and treatment planning, and ongoing technological innovations in biopsy devices aimed at improving safety and efficacy. These trends are poised to drive significant advancements in kidney biopsy procedures and contribute to improved patient care and outcomes in the field of nephrology.

The increasing incidence of renal cancer is poised to drive growth in the kidney biopsy market. Renal cancer involves the unchecked proliferation of abnormal kidney cells, influenced by factors such as lifestyle changes, environmental toxins, and improved diagnostic methods leading to higher detection rates. Kidney biopsies play a crucial role in diagnosing and managing renal cancer by confirming the presence of cancerous cells, determining cancer stage, guiding treatment strategies, monitoring treatment response, and providing prognostic insights. For example, Cancer Research UK projects an anticipated rise in new kidney cancer cases from approximately 16,300 in 2023 to about 21,900 by 2025, underscoring the escalating demand for kidney biopsy services.

Leading companies in the kidney biopsy market are innovating by integrating artificial intelligence (AI) to enhance diagnostic precision, streamline procedures, and optimize patient outcomes. AI technology improves kidney biopsy analysis by enhancing image interpretation, supporting diagnostic decisions, assisting in treatment planning, offering predictive analytics, and advancing research in kidney diseases. For instance, Aiosyn, a Netherlands-based software firm, introduced the NephroPath platform in March 2024. This platform utilizes computational pathology algorithms to analyze histological biomarkers in kidney biopsies, including tissue type identification, measurement of interstitial fibrosis, and precise quantification and evaluation of glomeruli. Such AI-driven analysis ensures consistent, detailed, and reproducible assessment of renal pathology biomarkers, overcoming limitations associated with traditional scoring methods and reducing observer subjectivity.

In October 2022, Halma plc, a UK-based technology company, acquired IZI Medical Products for $176 million. This strategic acquisition enhances Halma plc's footprint in the kidney biopsy sector by integrating IZI Medical's advanced core biopsy devices. These devices are utilized across various anatomical sites, including kidneys, thyroid, intra-abdominal areas, and liver, aimed at improving the safety, accuracy, and efficacy of biopsy procedures. This acquisition underscores Halma plc's commitment to advancing biopsy technologies to benefit both patients and healthcare providers.

Major companies operating in the kidney biopsy market are Cardinal Health, Pfizer Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., AstraZeneca, Medtronic, Siemens Healthcare Private Limited, Becton, Dickinson and Company, Stryker Healthcare, Baxter International Inc., Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., Zimmer Biomet, Agilent Technologies Inc., Olympus Corporation, Hitachi High-Tech Corporation, Beckman Coulter Inc., B. Braun, Sysmex Corporation, Cook Medical, Bio-Rad Laboratories Inc., Integra LifeSciences Corporation, Merit Medical Systems, Leica Biosystems Nussloch GmbH, Argon Medical Devices Inc., BioGenex

North America was the largest region in the kidney biopsy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the kidney biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The kidney biopsy market consists of revenues earned by entities by providing services such as diagnostic biopsy, therapeutic biopsy, post-biopsy care and monitoring, and pathological analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The kidney biopsy market also includes sales of biopsy needles, biopsy guns, biopsy trays and kits, and biopsy specimen containers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Kidney Biopsy Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on kidney biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for kidney biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The kidney biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Percutaneous Biopsy; Surgical Biopsy
2) By Indication: Kidney Failure; Kidney Transplant; Hematuria; Proteinuria
3) By End-User: Hospitals And Clinics; Urology Centers; Tertiary Care Centers; Other End-Users
Companies Mentioned: Cardinal Health; Pfizer Inc.; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; AstraZeneca
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18901

1. Executive Summary

2. Kidney Biopsy Market Characteristics

3. Kidney Biopsy Market Trends And Strategies

4. Kidney Biopsy Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Kidney Biopsy Market Size and Growth

5.1. Global Kidney Biopsy Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Kidney Biopsy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Kidney Biopsy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Kidney Biopsy Market Segmentation

6.1. Global Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Percutaneous Biopsy
Surgical Biopsy
6.2. Global Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Kidney Failure
Kidney Transplant
Hematuria
Proteinuria
6.3. Global Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals And Clinics
Urology Centers
Tertiary Care Centers
Other End-Users

7. Kidney Biopsy Market Regional And Country Analysis

7.1. Global Kidney Biopsy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Kidney Biopsy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Kidney Biopsy Market

8.1. Asia-Pacific Kidney Biopsy Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Kidney Biopsy Market

9.1. China Kidney Biopsy Market Overview
9.2. China Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Kidney Biopsy Market

10.1. India Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Kidney Biopsy Market

11.1. Japan Kidney Biopsy Market Overview
11.2. Japan Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Kidney Biopsy Market

12.1. Australia Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Kidney Biopsy Market

13.1. Indonesia Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Kidney Biopsy Market

14.1. South Korea Kidney Biopsy Market Overview
14.2. South Korea Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Kidney Biopsy Market

15.1. Western Europe Kidney Biopsy Market Overview
15.2. Western Europe Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Kidney Biopsy Market

16.1. UK Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Kidney Biopsy Market

17.1. Germany Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Kidney Biopsy Market

18.1. France Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Kidney Biopsy Market

19.1. Italy Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Kidney Biopsy Market

20.1. Spain Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Kidney Biopsy Market

21.1. Eastern Europe Kidney Biopsy Market Overview
21.2. Eastern Europe Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Kidney Biopsy Market

22.1. Russia Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Kidney Biopsy Market

23.1. North America Kidney Biopsy Market Overview
23.2. North America Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Kidney Biopsy Market

24.1. USA Kidney Biopsy Market Overview
24.2. USA Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Kidney Biopsy Market

25.1. Canada Kidney Biopsy Market Overview
25.2. Canada Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Kidney Biopsy Market

26.1. South America Kidney Biopsy Market Overview
26.2. South America Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Kidney Biopsy Market

27.1. Brazil Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Kidney Biopsy Market

28.1. Middle East Kidney Biopsy Market Overview
28.2. Middle East Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Kidney Biopsy Market

29.1. Africa Kidney Biopsy Market Overview
29.2. Africa Kidney Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Kidney Biopsy Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Kidney Biopsy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Kidney Biopsy Market Competitive Landscape And Company Profiles

30.1. Kidney Biopsy Market Competitive Landscape
30.2. Kidney Biopsy Market Company Profiles
- 30.2.1. Cardinal Health
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Pfizer Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Merck & Co. Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Thermo Fisher Scientific Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. AstraZeneca
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Kidney Biopsy Market Other Major And Innovative Companies

31.1. Medtronic
31.2. Siemens Healthcare Private Limited
31.3. Becton, Dickinson and Company
31.4. Stryker Healthcare
31.5. Baxter International Inc.
31.6. Boston Scientific Corporation
31.7. F. Hoffmann-La Roche Ltd.
31.8. Zimmer Biomet
31.9. Agilent Technologies Inc.
31.10. Olympus Corporation
31.11. Hitachi High-Tech Corporation
31.12. Beckman Coulter Inc.
31.13. B. Braun
31.14. Sysmex Corporation
31.15. Cook Medical

32. Global Kidney Biopsy Market Competitive Benchmarking

33. Global Kidney Biopsy Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Kidney Biopsy Market

35. Kidney Biopsy Market Future Outlook and Potential Analysis

35.1 Kidney Biopsy Market In 2028 - Countries Offering Most New Opportunities
35.2 Kidney Biopsy Market In 2028 - Segments Offering Most New Opportunities
35.3 Kidney Biopsy Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer